Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.

The Centers for Disease Control and Prevention's National Center for Emerging and Zoonotic Infectious Diseases is offering a cooperative agreement to reduce the burden of parasitic infections in the United States through evidence-based prevention and control activities. The scope of work is divided into three components: improving healthcare provider knowledge and practices for Chagas disease, strengthening public health efforts to monitor and control soil-transmitted helminth infections in the Southeastern United States, and targeting the prevention and control of other parasitic diseases like cyclosporiasis and toxoplasmosis. Project proposals must align with gold-standard science and evidence-based responses, and activities may not focus on malaria, amoebiasis, cryptosporidiosis, giardiasis, research, or international efforts. The agency expects to make approximately 11 awards over a five-year period of performance, with an estimated total program funding of $23,750,000 and individual awards ranging from $250,000 to $1,250,000. Applications must be submitted electronically by July 17, 2026, and inquiries can be directed to Project Officer Jamal Choice at qhi2@cdc.gov.